82
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.035
Exchange
XHKG - Hong Kong Exchange
-0.029 B
Last period CFO ,CNY
-211%
CFO has decreased in 5 years
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also Biosino Bio-Technology
Company Analysis
8247.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
8247.HK financial analysis by Eyestock methodology
Valuation
8247.HK valuation using historical relative method
Statements
8247.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
8247.HK dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
Biosino Bio-Technology`s CFO for the period ended 2024-06-30 is -0.029 B CNY
